Live Breaking News & Updates on Yizhe Wang

Stay updated with breaking news from Yizhe wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Princeton biotech to wind down operations

Princeton biotech to wind down operations
njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.

South Korea , Yi Larson , Yizhe Wang , Konstantin Poukalov , Concentra Biosciences , American Depositary Shares , Nasdaq Global , Janssen Pharmaceutica , New Brunswick Based Johnson , Chief Financial Officer Yi Larson ,

LianBio CEO steps down

LianBio CEO steps down
njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.

Adam Stone , Eli Lilly , Yizhe Wang , Konstantin Poukalov , Concentra Biosciences , Perceptive Advisors , Bio Executive Chairman Konstantin Poukalov ,

LianBio Announces Departure of Chief Executive Officer

LianBio Announces Departure of Chief Executive Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Katherine Smith , Yizhe Wang , Konstantin Poukalov , Adam Stone , Elizabeth Anderson , Vp Communications , Bio Announces Departure , Chief Executive , Chief Executive Officer , Lianbio Board , Chief Investment Officer , Perceptive Advisors , Interim Chief Executive , Executive Chairman ,

LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Entered into agreement with Bristol Myers Squibb for mavacamten in China and other Asian marketsPhase 3 data from EXPLORER-CN trial of mavacamten presented in an oral late-breaking science session at the European Society of Cardiology Congress 2023 with simultaneous publication in JAMA Cardiology Topline data announced from Phase 3 trial of TP-03 in Chinese Demodex blepharitis patientsCash, cash equivalents and marketable securities of $252.2 million as of September 30, 2023Strategic review ongo ....

United States , Hong Kong , Katherine Smith , Bristol Myers Squibb , Yizhe Wang , European Society Of Cardiology Congress , European Society Of Cardiology , European Society For Medical Oncology , Clinical Development Updates , Myokardia Inc , Exchange Commission , Research Development Expenses , European Society , Cardiology Congress , Chinese Demodex , Chief Executive Officer , Business Highlights , Mainland China , Medical Oncology , Greater China , Annual Report , Months Ended September , Clinical Development , European Society Of Cardiology , Clinical Trial , Mainland China ,